Recombinant human interferon beta-1a

( DrugBank: Interferon beta-1a, Human interferon beta, Interferon beta / KEGG DRUG: Interferon beta-1a )

1 disease

ID	Disease name (Link within this page)	Number of trials
26	HTLV-1-associated myelopathy	1

26. HTLV-1-associated myelopathy

Clinical trials : 29 / Drugs : 47 - (DrugBank : 29) / Drug target genes : 34 - Drug target pathways : 119

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00001785 (ClinicalTrials.gov)	September 1998	3/11/1999	Recombinant Human Interferon Beta-1a(Avonex) for the Treatment of Patients With HTLV-1-Associated My ...	Combined Virological and Immunological Evaluation of Treatment of Patients With Early HTLV-1-Associa ...	HTLV-I Infection;Spinal Cord Disease;Tropical Spastic Paraparesis	Drug: Recombinant human interferon beta-1a	National Institute of Neurological Disorders and Stroke (NINDS)	NULL	Completed	N/A	N/A	Both	12	Phase 2	United States

First Previous1Next Last